Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels

被引:42
|
作者
Depardieu, Florence [1 ]
Bikard, David [1 ]
机构
[1] Inst Pasteur, Grp Biol Synthese, F-75015 Paris, France
基金
欧洲研究理事会;
关键词
CRISPRi; dCas9; Knockdown; Gene silencing; Staphylococcus aureus; Escherichia coli; RNA; SEQUENCE; INTERFERENCE; PLASMIDS; PROTEIN; FAMILY; CAS9; TRANSFORMATION; MUTAGENESIS; RESISTANCE;
D O I
10.1016/j.ymeth.2019.07.024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The catalytic null mutant of the Cas9 endonuclease from the bacterial CRISPR immune system, known as dCas9, can be guided by a small RNA to bind DNA sequences of interest and block gene transcription in a strategy known as CRISPRi. This powerful gene silencing method has already been used in a large number of species and in high throughput screens. Here we provide detailed design rules, methods and novel vectors to perform CRISPRi experiments in S. aureus and in E. coli, using the well characterized dCas9 protein from S. pyogenes. In particular, we describe a vector based on plasmid pC194 which is broadly used in Firmicutes, as well as a vector based on the very broad host-range rolling circle plasmid pLZ12, reported to replicate in both Firmicutes and Proteobacteria. A potential caveat of adapting dCas9 tools to various bacterial species is that dCas9 was shown to be toxic when expressed too strongly. We describe a method to optimize the expression level of dCas9 in order to avoid toxicity while ensuring strong on-target repression activity. We demonstrate this method by optimizing a pLZ12 based vector originally developed for S. aureus so that it can work in E. colt. This article should provide all the resources required to perform CRISPRi experiments in a broad range of bacterial species.
引用
收藏
页码:61 / 75
页数:15
相关论文
共 50 条
  • [21] Engineered dCas9 with reduced toxicity in bacteria: implications for genetic circuit design
    Zhang, Shuyi
    Voigt, Christopher A.
    NUCLEIC ACIDS RESEARCH, 2018, 46 (20) : 11115 - 11125
  • [22] Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
    Moses, Colette
    Nugent, Fiona
    Waryah, Charlene Babra
    Garcia-Bloj, Benjamin
    Harvey, Alan R.
    Blancafort, Pilar
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 14 : 287 - 300
  • [23] Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers
    Gao, Xuefei
    Tsang, Jason C. H.
    Gaba, Fortis
    Wu, Donghai
    Lu, Liming
    Liu, Pentao
    NUCLEIC ACIDS RESEARCH, 2014, 42 (20)
  • [24] Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira
    L. G. V. Fernandes
    L. P. Guaman
    S. A. Vasconcellos
    Marcos B. Heinemann
    M. Picardeau
    A. L. T. O. Nascimento
    Scientific Reports, 9
  • [25] Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira
    Fernandes, L. G. V.
    Guaman, L. P.
    Vasconcellos, S. A.
    Heinemann, Marcos B.
    Picardeau, M.
    Nascimento, A. L. T. O.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] Improvement of 2,3-butanediol production by dCas9 gene expression system in Saccharomyces cerevisiae
    Morita, Keisuke
    Seike, Taisuke
    Ishii, Jun
    Matsuda, Fumio
    Shimizu, Hiroshi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2022, 133 (03) : 208 - 212
  • [27] dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer
    Zamberi, Nurul Nadia Mohamad
    Abuhamad, Asmaa Y.
    Low, Teck Yew
    Mohtar, M. Aiman
    Syafruddin, Saiful Effendi
    CRISPR JOURNAL, 2024, 7 (02): : 73 - 87
  • [28] CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
    Cai, Ruijie
    Lv, Runyu
    Shi, Xin'e
    Yang, Gongshe
    Jin, Jianjun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [29] Exploring the virulence gene interactome withCRISPR/dCas9 in the human malaria parasite
    Bryant, Jessica M.
    Baumgarten, Sebastian
    Dingli, Florent
    Loew, Damarys
    Sinha, Ameya
    Claes, Aurelie
    Preiser, Peter R.
    Dedon, Peter C.
    Scherf, Artur
    MOLECULAR SYSTEMS BIOLOGY, 2020, 16 (08)
  • [30] In vitro activation of anti-cancer gene expression by delivery of CRISPR/ dCas9 ribonucleoproteins to suppress glioblastoma
    Lee, Mei-Hwa
    Thomas, James L.
    Lin, Yu-Ling
    Lin, Hung-Yin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 308